radium has been researched along with prednisone in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.83) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 7 (29.17) | 2.80 |
| Authors | Studies |
|---|---|
| Corby, DG; Louro, JM; Oquendo-Cabrera, A | 1 |
| Waldeyer, L | 1 |
| TRONCONI, G | 1 |
| van BOUWDYK BASTIAANSE, M | 1 |
| FAYOS, JV | 1 |
| Kang, I; Kang, Y; Kim, JW; Petrylak, DP; Shin, MS | 1 |
| Harrelson, SS; Mariados, NF; Mehlhaff, BA; Nordquist, LT; Shore, ND; Steere, KJ; Tutrone, RF | 1 |
| Cicero, G; Costa, RP; De Luca, R; Murabito, A; Tripoli, V | 1 |
| Gourd, E | 1 |
| Berruti, A; Dalla Volta, A; Formenti, AM | 1 |
| Boegemann, M; Heidenreich, A; Higano, C; Kakehi, Y; Karyakin, O; Kimura, G; Krissel, H; Matsubara, N; Matveev, V; Miller, K; Nahas, WC; Ng, QS; Nolè, F; Parker, C; Piulats, JM; Rosenbaum, E; Saad, F; Shen, J; Smith, M; Teufel, M; Tombal, B; Wagner, V; Zhang, A; Zucca, LE | 1 |
| Spratt, DE | 1 |
| Cursano, MC; De Giorgi, U; Iuliani, M; Paganelli, G; Santini, D | 1 |
| Hindié, E; Morgat, C | 1 |
| van der Poel, H | 1 |
| Fujii, Y; Hinotsu, S; Izumi, K; Kimura, G; Mizokami, A | 1 |
| Figg, WD; Knechel, MA; Schmidt, KT | 1 |
| Hosono, M; Kakehi, Y; Kikukawa, H; Kimura, G; Kinuya, S; Krissel, H; Matsubara, N; Mizokami, A; Nagamori, S; Nakamura, M; Siegel, J; Uemura, H | 1 |
| George, DJ; Higano, CS; Jiao, X; Kalinovsky, J; Miller, K; Saad, F; Sartor, O; Shore, N; Sternberg, CN; Tangirala, K; Tombal, B | 1 |
| Abou Chakra, M; Dellis, A; Moussa, M; Papatsoris, A; Sryropoulou, D | 1 |
| Albany, C; Dawson, NA; Higano, CS; Mehlhaff, BA; Nordquist, LT; Patel, KR; Petrylak, DP; Quinn, DI; Sartor, O; Siegel, J; Trandafir, L; Vaishampayan, UN; Wagner, VJ | 1 |
| Agarwal, N; Bruno, A; George, D; Guo, H; Higano, CS; Jiao, X; Miller, K; Saad, F; Sandström, P; Sartor, O; Shore, N; Sternberg, CN; Tombal, B; Verholen, F | 1 |
| Dai, JD; Shen, PF; Sun, GX; Wang, MH; Xu, NW; Zeng, H; Zeng, YH; Zhang, XM; Zhao, JG | 1 |
3 review(s) available for radium and prednisone
| Article | Year |
|---|---|
Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases.
Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase II as Topic; Humans; Male; Prednisone; Proportional Hazards Models; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Treatment Outcome | 2016 |
Pharmacotherapeutic strategies for castrate-resistant prostate cancer.
Topics: Abiraterone Acetate; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Humans; Immunotherapy; Male; Nitriles; Phenylthiohydantoin; Prednisone; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids; Tissue Extracts | 2020 |
The safety of radium-223 combined with new-generation hormonal agents in bone metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Fractures, Bone; Humans; Male; Network Meta-Analysis; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium | 2023 |
4 trial(s) available for radium and prednisone
| Article | Year |
|---|---|
eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer.
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prednisone; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Treatment Outcome | 2018 |
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
Topics: Abiraterone Acetate; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Double-Blind Method; Fractures, Bone; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Prednisolone; Prednisone; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radium | 2019 |
A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study.
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Neoplasms; Disease-Free Survival; Double-Blind Method; Fractures, Bone; Humans; Male; Middle Aged; Placebos; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome | 2020 |
A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide.
Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Humans; Male; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Tomography, X-Ray Computed | 2021 |
17 other study(ies) available for radium and prednisone
| Article | Year |
|---|---|
Thrombocytopenia in a patient with a relatively small facial hemangioma. Successful management with irradiation after failure of prednisone therapy.
Topics: Facial Neoplasms; Female; Hemangioma; Humans; Infant; Prednisone; Radium; Thrombocytopenia | 1969 |
[The further course of Hand-Schueller-Christian disease of the cervix and vagina].
Topics: Adult; Chlortetracycline; Female; Histiocytosis, Langerhans-Cell; Humans; Lung Neoplasms; Menstruation Disturbances; Prednisone; Radium; Sulfisomidine; Uterine Cervical Diseases; Vaginal Diseases; Vulvar Neoplasms | 1966 |
[Prevention and therapy of vagino-proctitis caused by radium].
Topics: Disease; Female; Humans; Prednisone; Proctitis; Radium; Rectal Diseases; Rectum; Uterine Cervical Neoplasms; Vaginitis | 1960 |
[Operation of a large radium fistula].
Topics: Female; Fistula; Humans; Prednisolone; Prednisone; Radiation Injuries; Radium; Vesicovaginal Fistula | 1963 |
A COMPLICATION OF STEROID TREATMENT AFTER RADIOTHERAPY OF CARCINOMA OF THE UTERINE CERVIX; REPORT OF A CASE.
Topics: Carcinoma, Squamous Cell; Cobalt Isotopes; Female; Geriatrics; Humans; Hydrocortisone; Necrosis; Neoplasms; Peritonitis; Prednisone; Radiation Injuries; Radium; Toxicology; Uterine Cervical Neoplasms; Vagina | 1964 |
Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Bone Neoplasms; CD8-Positive T-Lymphocytes; Humans; Interferon-gamma; Interleukin-13; Male; Middle Aged; Prednisone; Programmed Cell Death 1 Receptor; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Docetaxel; Humans; Italy; Male; Middle Aged; Prednisone; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Retrospective Studies; Taxoids | 2018 |
EMA guidance on radium-223 dichloride in prostate cancer.
Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; European Union; Fractures, Bone; Humans; Male; Prednisone; Prostatic Neoplasms; Radioisotopes; Radium; Survival Rate | 2018 |
Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the Culprit.
Topics: Abiraterone Acetate; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Fractures, Bone; Humans; Male; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome | 2019 |
Combination therapies in prostate cancer: proceed with caution.
Topics: Abiraterone Acetate; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium | 2019 |
Early use of abiraterone and radium-223 in metastatic prostate cancer.
Topics: Abiraterone Acetate; Androstenes; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium | 2019 |
Early use of abiraterone and radium-223 in metastatic prostate cancer.
Topics: Abiraterone Acetate; Androstenes; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium | 2019 |
Re: Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients with Castration-resistant Prostate Cancer and Bone Metastases (ERA 223): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial.
Topics: Abiraterone Acetate; Bone Neoplasms; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium | 2019 |
Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial.
Topics: Abiraterone Acetate; Bone Density; Bone Neoplasms; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium | 2019 |
Combination treatment in metastatic castration-resistant prostate cancer: can we safely boost efficacy by adding radium-223?
Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium | 2020 |
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase III as Topic; Denosumab; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Zoledronic Acid | 2020 |
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.
Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Benzamides; Bone Neoplasms; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies | 2022 |